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The functional relationship between the two subcellular compartments involved in catabolism of triglycerides, i.e. lyso- 
somes and lipid-containing cytoplasmic vacuoles, has been investigated using cultured fibroblasts from patients affected 
with two different genetic lipid (triacylglycerol) storage disorders: Wolman disease and multisystemic lipid storage myopa- 
thy. As shown by metabolic studies in intact cultured cells, lysosomal degradation of exogenous labelled triacylglycerols 
(incorporated into lipoproteins and internalized via the apo B/E receptor pathway) was blocked in Wolman cells, whereas 
catabolism of endogenously biosynthesized triacylglycerols was in the normal range. In contrast, in fibroblasts from 
multisystemic lipid storage myopathy, the degradation of endogenous triacylglycerols was blocked, whereas that of exo- 
genous triacylglycerols (i.e. from lipoproteins) was normal. This comparative study demonstrates that the lysosomal and 
cytoplasmic ompartments are functionally independent. Enzymatic studies allow one to discriminate clearly between 
3 lipases and 2 carboxylesterases the role of which is discussed. 
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1. INTRODUCTION 
The triacylglycerols stored in cultured cells can 
originate from extracellular lipoproteins or intra- 
cellular biosynthesis of lipids. 
The cellular uptake of lipoproteins is receptor- 
mediated [l-3] and partially receptor-independent 
[4]. Internalized lipoproteins contained in the en- 
dosomal compartment can be excreted back by 
retro-endocytosis [5] or be able to reach the lyso- 
somal compartment [3] in which they are rapidly 
degraded by acid hydrolases. In Wolman disease 
[6] and cholesteryl ester storage disease [7], the acid 
lipase deficiency results in the lysosomal catabolic 
block of neutral lipids and their subsequent ac- 
cumulation [8]. 
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Endogenous triacylglycerols are synthesized, in 
the cytoplasmic ompartment, via the phosphatidic 
acid pathway; high cellular influx of long-chain 
fatty acids results in dramatic cytoplasmic storage 
of triacylglycerols, which is completely reversible 
after stopping the cellular loading in fatty acids 
[9, lo]. We have recently demonstrated that the 
catabolic block of endogenous triacylglycerols 
stored in cytoplasmic vacuoles [11,12] is the 
primary metabolic defect involved in multisystemic 
lipid storage myopathy 113,141. 
The functional relationship between the lyso- 
somal and cytoplasmic compartments (where 
neutral lipids can be accumulated) is poorly under- 
stood and a connection between these compart- 
ments has been recently suggested by Sauro et al. 
[ 151 who proposed the hypothesis of a role for lyso- 
somal lipase in the degradation of triacylglycerols 
stored in the cytoplasm. 
Comparative analysis of triacylglycerol catabo- 
lism in cultured fibroblasts from the above-quoted 
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Fig.1. Metabolism of exogenous (left) and endogenous (right) 
fluorescent riacylglycerols in fibroblasts from Wolman disease 
(- - -), multisystemic lipid storage myopathy (- - *) and con- 
trols (- ). (Inset) Ratio of endogenous fluorescent riacyl- 
glycerols to fluorescent phospholipids (log scale) during the 
chase. Pulse-chase xperiments and lipid analyses were perform- 
ed under the conditions indicated in section 2. 
genetic diseases allows one to conclude that the 
lysosomal and cytoplasmic compartments are in- 
dependent (no appreciable transfer of these lipids 
occurs between the two subcellular compartments). 
The characteristic properties of the cellular lipases 
and carboxylesterases are reported and their func- 
tional role is discussed. 
2. MATERIALS AND METHODS 
The sources and routes for synthesis of chemicals have been 
previously reported [16-191. 
Cell culture of skin fibroblasts was performed in culture 
flasks or petri dishes, using RPM1 1640 supplemented with 
Ultroser (2@/0), fetal calf serum or human lipoproteins, under 
the reported conditions [ 14,171. 
Enzyme assays for cellular lipases and carboxylesterases con- 
tained labelled substrates, either [3H]triolein (lo6 dpm/ml) or 
15 pm0111 fluorescent tripyrenebutanoylglycerol, 500 pmol/l 
unlabelled triacylglycerol, 1 g/l Triton X-100 (and for the lyso- 
somal lipase standard assay, 2 mmol/l taurocholate), 0.2 mol/l 
buffer (citrate-phosphate from pH 3.5 to 7.2 and Tris-HCl from 
pH 7.2 to 9.0) and enzyme solution (final volume, lOO,& in- 
cubation for 1 h at 37’C). The fatty acids liberated were quan- 
tified radiometrically and fluorometrically as in [18,19]. Pro- 
teins were determined by the method of Lowry et al. [20]. 
Pulse-chase xperiments on exogenous triacylglycerols utiliz- 
ed human LDL, prepared by sequential centrifugation as 
reported [17] and labelled with pyrenedecanoyldioleylglycerol 
(ProOOG) according to Roberts et al. 1211: PtoOOG (500 nmol) 
was solubilized in DMSO (100 rl), mixed with 6 ml sterile lipo- 
protein-deficient serum and added to 1 ml (4 mg apo B) LDL 
solution; after 12 h preincubation at 37”C, fluorescent LDL 
were isolated by ultracentrifugation, dialyzed and mixed with 
RPM1 1640 (200 /cg apo B per ml culture medium). This mixture 
was used for a 72 h pulse, then medium was removed, cells were 
washed with PBS containing 1% fatty acid-free serum albumin 
and incubated in standard culture medium for 12 days chase. 
For pulse-chase experiments with fluorescent fatty acids, 
pyrenedecanoic acid (PIo) solubilized in DMSO (33 nmol/ml) 
was added to the culture medium (RPM1 1640 supplemented 
with 2% Ultroser). At the end of the pulse period (1 day), cells 
were washed as indicated above and chased for 6 days. 
Fluorescent lipids were extracted following the procedure of 
Folch et al. [22], separated by TLC and fluorometrically quan- 
tified after scraping and hydrolysis as described [23]. 
Table 1 
Distribution of fluorescent lipids in subcellular fractions of Wolman and control fibro- 
blasts fed with PIO for 24 h 
Subcellular fraction Fluorescent liuids B-Hexos- 
Triacyl- Phospho- Fatty 
aminidase 
glycerols lipids acids 
Wolman 
Homogenate 
Lysosomes/mitochondria 
Cytosol/membranes 
45 40 15 1050 
5 5 90 4200 
42 38 20 700 
Controls 
Homogenate 44 40 16 980 
Lysosomes/mitochondria 5 6 89 4300 
Cytosol/membranes 38 41 21 600 
Lipid contents are expressed as the percentage of total fluorescent lipids per subcellular 
fraction. &Hexosaminidase activities are expressed as nmol’ h-’ . mg-’ 
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Fig.2. Hydrolysis of [3H]trioiein (diluted with unlabelled 
triolein) by lipases (A) and of tripyrenebutanoylglycerol (diluted 
in tributyrin) by carboxylesterases (B) from cultured fibroblasts 
from Wolman disease (---), multisystemic lipid storage 
myopathy (- - -) and controls (-). Assays were under the 
conditions described in section 2, with enzyme activities being 
expressed as nmol total oleic acid liberated/h and per mg cell 
protein (A) and nmol pyrenebutanoic acid liberated/h per mg 
cell protein (B). 
3. RESULTS 
As shown in fig. 1, lipoproteins containing fluo- 
rescent triacylglycerols were taken up by controls 
and lipidotic cells: at the end of the pulse, the 
cellular content of fluorescent triacylglycerols was 
2-fold greater in Wolman than in control and myo- 
pathic fibroblasts. During the chase period, the in- 
ternalized fluorescent triacylglycerols were rapidly 
degraded in normal and myopathic cells (half-life 
-2 days), whereas in Wolman cells, they under- 
went a slight decrease during the first 3 days 
(perhaps, due to retro-endocytosis) and then 
reached a plateau with only minor degradation 
(half-life - 40-60 days). 
Studies of the metabolism of endogenous lipids 
biosynthesized from fluorescent Pro fatty acid, 
showed, at the end of the 24 h pulse period, a 
7-fold higher level of fluorescent riacylglycerols in 
multisystemic lipid storage myopathy vs control or 
Wolman cells (fig.1). During the chase, the 
degradation of fluorescent triacylglycerols was 
blocked in myopathic fibroblasts, in contrast to 
Wolman and control cells. 
Lipid analyses of the subcellular fractions (table 
1) showed that in Wolman (as well as control) 
fibroblasts pulsed by Pro, the major part of the 
fluorescence of the lysosome-mitochondrial frac- 
tion was due to free fatty acids, without appre- 
ciable accumulation of fluorescent triacylglycerols 
(which were only detected in the membrane-cytosol 
fraction of the pulsed cells): these data demon- 
strate that the triacylglycerols synthesized in the 
cytoplasm are not transferred to the lysosomal 
compartment. 
Enzymatic studies of the cellular lipases allowed 
us to discriminate clearly between 5 triacylglycerol- 
hydrolyzing enzymes (fig.2, table 2): 3 lipases 
(specific to long-chain triacylglycerols and resistant 
to diethyl-p-nitrophenyl phosphate or E~oo) and 2 
carboxylesterases (specific to short-chain triacyl- 
Table 2 
Comparison of characteristic properties of the lipases and carboxylesterases of cultured fibroblasts 
pH 4.0- 
Lipase 
pH 5.5- 
Lipase 
pH 5.5 
Carboxyl- 
esterase 
pH 7- 
Lipase 
pH 7.5- 
Carboxyl- 
esterase 
Acyl chain length specificity long long short long short 
pH optimum 4.0 5.5 5.5 7.0 7.5 
Heat stability (30 min at 50°C) 85 45 25 70 20 
Effecters 
Taurocholate (0.5 mmol/l) 140 115 125 110 70 
Taurocholate (2.5 mmol/l) 250 55 60 85 55 
p-Chloromercuribenzoate (1 mmol/l) 42 nd 100 2 84 
EDTA (10 mmol/l) 120 135 35 115 50 
NaCl (1 mol/l) 9 42 6 117 5 
Eem (lo-* mmol/l) 90 87 15 102 5 
Results are expressed as percentage of enzyme activity measured before heat treatment and in the absence of any effector 
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glycerols and inhibited by E~oo). The lysosomal en- 
zyme was severely deficient in Wolman cells (fig.2), 
but surprisingly none of the other lipases was defi- 
cient in the fibroblasts from multisystemic lipid 
storage myopathy. 
4. DISCUSSION 
The present data clearly demonstrate that the 
block of exogenous triacylglycerols is nearly com- 
plete in Wolman fibroblasts: the residual de- 
gradative activity in living cultured Wolman fibro- 
blasts can be evaluated as being less than 5% (on 
the basis of the triacylglycerol half-life for Wolman 
vs control cells). This low level of residual catabolic 
activity is in agreement with the very low value for 
the acid lipase determined in vitro (c 5% of con- 
trol) (fig.2). It is also consistent with the values 
reported by Brown et al. [24] and Goldstein and co- 
workers [25] for degradation of cholesteryl esters, 
but significantly lower than that determined by 
Burton et al. [26] who probably overestimated the 
apparent residual activity because of the retro- 
endocytosis process [5] occurring at the beginning 
of the chase. Therefore, the severe catabolic block 
in Wolman fibroblasts demonstrates that triacyl- 
glycerols stored in lysosomes cannot reach, to an 
appreciable extent, the cytoplasmic compartment 
where endogenously biosynthesized triacylglycer- 
01s are degraded at the normal rate (as shown by 
studying endogenous triacylglycerol catabolism). 
Conversely, endogenous cytoplasmic fluorescent 
triacylglycerols biosynthesized from internalized 
fatty acids are not accumulated in Wolman lyso- 
somes, as indicated by the absence of labelled 
triacylglycerols in the fractionated lysosomes (table 
1) and by their complete catabolism in Wolman 
fibroblasts, similarly to controls (fig.1): therefore, 
this demonstrates that cytoplasmic triacylglycerols 
do not reach the lysosomal compartment. This 
conclusion completely agrees with results obtained 
from studying metabolism of endogenous triacyl- 
glycerols (biosynthesized from labelled fatty acids) 
in multisystemic lipid storage myopathy fibro- 
blasts. The latter cells exhibited severe catabolic 
block of these lipids and their subsequent intra- 
cytoplasmic accumulation, although lysosomal 
degradation was normal in these cells (as demon- 
strated by studies of the acid lipase and the 
catabolism of exogenous triacylglycerols). This 
38 
shows that cytoplasmic granules containing endo- 
genous triacylglycerols [lo] are unable to fuse with 
lysosomes (where the catabolism of exogenous tri- 
acylglycerols is normal). 
The enzymatic study demonstrates that catabolic 
block of lysosomal degradation of exogenous tri- 
acylglycerols is due to a deficiency in lysosomal 
lipase and that other lipases or carboxylesterases 
do not contribute to this defect. In contrast, in 
multisystemic lipid storage myopathy, we were un- 
able to detect any enzyme deficiency: this suggests 
that another factor is probably implicated in de- 
gradation of cytoplasmic triacylglycerols, either an 
activator (not necessary in vitro) or a factor di- 
recting the enzyme to the substrate-containing 
compartment. 
In conclusion, the present experiments utilizing 
fibroblasts from two inherited triacylglycerol 
storage disorders demonstrate the existence of two 
separate metabolic compartments of triacyl- 
glycerols (lysosomes and cytoplasmic granules): 
these compartments are unable to exchange their 
triacylglycerol contents and can be considered to be 
independent. Only hydrolysis products (i.e. fatty 
acids, glycerol and cholesterol) are able to move 
out of these compartments and be re-utilized in 
cellular biosynthetic pathways. 
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